Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 3.24x is 11% below its 5-year average of 3.63x, near the high end of its 5-year range (-107.81x–27.19x).
69.43% above its 12-month average of 1.91x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.61x.
INTEREST COVERAGE RATIO
3.24x
INTEREST COVERAGE RATIO AVG TTM
1.91x
INTEREST COVERAGE RATIO AVG 3Y
3.13x
INTEREST COVERAGE RATIO AVG 5Y
3.63x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+69.43%
CURRENT VS 3Y AVG
+3.41%
CURRENT VS 5Y AVG
-10.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+155.96%
vs the sector median at left
biote Corp.
Market Cap
$51.61M
Interest Coverage Ratio
3.24x
TTM Avg
1.91x
3Y Avg
3.13x
5Y Avg
3.63x
Market Cap
$51.91M
Interest Coverage Ratio
-557.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.33M
Interest Coverage Ratio
-14.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.38M
Interest Coverage Ratio
-13.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.66M
Interest Coverage Ratio
-9.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.45M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.08M
Interest Coverage Ratio
N/A
TTM Avg
254.37x
3Y Avg
222.37x
5Y Avg
222.37x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| biote Corp. (BTMD) | $51.61M | 3.24x | 1.91x | 3.13x | 3.63x |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.91M | -557.72x | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -14.01x | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.38M | -13.25x | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.66M | -9.08x | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $50.54M | -8.61x | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | -6.14x | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.08M | N/A | 254.37x | 222.37x | 222.37x |
| INmune Bio, Inc. (INMB)vs › | $50.51M | N/A | N/A | N/A | N/A |
Interest Coverage
3.2x
Debt/Equity
N/A
Current Ratio
1.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.61x |
| 2026-03-31 | 1.61x |
| 2025-12-31 | 2.76x |
| 2025-09-30 | 3.02x |
| 2025-06-30 | 3.77x |
| 2025-03-31 | 3.34x |
| 2024-12-31 | 0.86x |
| 2024-09-30 | 3.44x |
| 2024-06-30 | 2.46x |
| 2024-03-31 | 6.28x |
| 2023-12-31 | 3.57x |
| 2023-09-30 | 4.97x |
| 2023-06-30 | 4.66x |
| 2023-03-31 | 4.79x |
| 2022-12-31 | 3.35x |
| 2022-09-30 | 5.55x |
| 2022-06-30 | -107.81x |
| 2022-03-31 | 27.19x |
| 2021-12-31 | 15.93x |
| 2021-09-30 | 23.39x |
| 2021-06-30 | 24.14x |
| 2021-03-31 | 19.09x |
